MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000 i 4500
001 in00003732421
005 20211120180407.0
006 m o d f
007 cr mn|||||||||
008 160811s2006 dcua ob f000 0 eng c
035 |a (OCoLC)ocn956501056 
040 |a GPO  |b eng  |e rda  |e pn  |c GPO  |d MvI  |d UtOrBLW 
042 |a pcc 
043 |a n-us--- 
049 |a WWW 
074 |a 0445-B-07 (online) 
086 0 |a HE 1.75:OEI-01-04-00390 
088 |a OEI-01-01-04-00390 
110 1 |a United States.  |b Department of Health and Human Services.  |b Office of Inspector General,  |e author. 
245 1 0 |a FDA's monitoring of postmarketing study commitments. 
246 3 0 |a Food and Drug Administration's monitoring of postmarketing study commitments 
246 1 |i Running title:  |a FDA's monitoring of postmarketing study commitments 
264 1 |a [Washington, D.C.] :  |b Department of Health and Human Services, Office of Inspector General,  |c 2006. 
300 |a 1 online resource (iv, 38 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Title from title screen (viewed Aug 9, 2016). 
500 |a "June 2006." 
500 |a "OEI-01-04-00390." 
504 |a Includes bibliographical references (pages 23-28). 
610 1 0 |a United States.  |b Food and Drug Administration  |x Rules and practice. 
650 0 |a Drugs  |z United States  |x Testing.  |0 http://id.loc.gov/authorities/subjects/sh2009123883 
650 0 |a Clinical trials  |x Government policy  |z United States. 
610 1 0 |a United States.  |t Food and Drug Administration Modernization Act of 1997.  |0 http://id.loc.gov/authorities/names/no98066240 
856 4 0 |u https://purl.fdlp.gov/GPO/gpo71089  |t 0 
999 f f |s 439c64b3-36a3-3544-a45b-74684b729182  |i dad7b4f9-30e1-3f76-b9c8-ba126ef977a6  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |d Available Online  |t 0  |e HE 1.75:OEI-01-04-00390  |h Superintendent of Documents classification 
998 f f |a HE 1.75:OEI-01-04-00390  |t 0  |l Available Online